Drug Combination Details
General Information of the Combination (ID: C21358) | |||||
---|---|---|---|---|---|
Name | Arsenic trioxide NP Info | + | 1,3-bis(2-chloroethyl)-1-nitrosourea Drug Info | ||
Structure |
![]() |
+ |
![]() |
||
Disease |
Nasopharyngeal cancer
[ICD-11: 2B6B]
|
Investigative | [1] | ||
Brain cancer
[ICD-11: 2A00]
|
Investigative | [1] | |||
Colorectal cancer
[ICD-11: 2B91]
|
Investigative | [1] | |||
Stomach cancer
[ICD-11: 2B72]
|
Investigative | [1] | |||
Lung cancer
[ICD-11: 2C25]
|
Investigative | [1] | |||
Click to Show/Hide the Whole Disease Information of This Combination |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. Enhancing Drug Efficacy by This Combination | ||||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [1] | |||||
Molecule(s)
Regulation |
Down-regulation | Expression | MAP1LC3A | Molecule Info |
Pathway MAP
|
|
Up-regulation | Cleavage | PARP1 | Molecule Info |
Pathway MAP
|
||
In-vitro Model | HONE-1 | CVCL_8706 | Nasopharyngeal carcinoma | Homo sapiens | ||
DBTRG-05MG | CVCL_1169 | Anaplastic astrocytoma | Homo sapiens | |||
HT-29 | CVCL_0320 | Colon adenocarcinoma | Homo sapiens | |||
NCI-H460 | CVCL_0459 | Lung large cell carcinoma | Homo sapiens | |||
A2058 | CVCL_1059 | Amelanotic melanoma | Homo sapiens | |||
MCF-7 | CVCL_0031 | Invasive breast carcinoma | Homo sapiens | |||
TSGH | Gastric carcinoma | Homo sapiens | ||||
Experimental
Result(s) |
Combination of arsenic trioxide and BCNU synergistically triggers redox-mediated autophagic cell death in human solid tumors. |
References | ||||
---|---|---|---|---|
Reference 1 | Combination of arsenic trioxide and BCNU synergistically triggers redox-mediated autophagic cell death in human solid tumors. Free Radic Biol Med. 2011 Dec 15;51(12):2195-209. |

